Streetbeat News

Products Services

JANX

Janux Therapeutics' stock price increased following the announcement of positive updated clinical data for its two clinical programs.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:31 pm

PRZO

ParaZero announced its intention to enter the counter-drone market, signaling a strategic expansion of its business operations.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:26 pm

TM

Toyota Motor Corp (NYSE:TM) is recalling 280,663 trucks and SUVs in the U.S. due to a software glitch causing unexpected vehicle movement. The recall affects Tundra, Tundra hybrids, Lexus LX600 models, and Sequoia SUVs. Toyota will provide a free software update to fix the issue. This marks Toyota's third major recall in the past year, following a 'Do Not Drive' advisory for exploding Takata airbags and a recall for airbag deployment issues.

Portfolio Pulse from Benzinga Neuro

February 27, 2024 | 1:20 pm

COMM

CommScope (NASDAQ:COMM) announced its Comsearch AFC system received FCC certification for commercial deployment, enabling the use of 850 MHz of 6 GHz spectrum for unlicensed devices. This development supports a broad range of deployments including Wi-Fi 6E and Wi-Fi 7, enhancing signal strength and quality of service for various applications. The certification positions CommScope as a key player in providing comprehensive 6 GHz solutions, including its RUCKUS portfolio, for next-generation commercial networks.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:18 pm

G

Genpact (NYSE:G) has entered into a five-year digital transformation engagement with Tropicana Brands Group to reengineer its global business services and supply chain operations. The collaboration will focus on transforming finance and accounting operations through standardized processes, data analytics, and digital solutions, including S/4 HANA testing and AI implementation. This strategic partnership aims to streamline operations, enhance revenue, profitability, and innovation for Tropicana Brands Group.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:18 pm

CPRX

Catalyst Pharmaceuticals announced its participation in the 2024 MDA Clinical & Scientific Conference, presenting a poster on a registry for studying the long-term safety and quality of life in Duchenne muscular dystrophy patients treated with AGAMREE (vamorolone). The registry aims to track the progress of 250 male patients across 25 U.S. sites, with the first interim analysis expected in May 2025. AGAMREE, a novel corticosteroid with a unique mode of action, has shown promise in the VISION-DMD study and received U.S. FDA approval on October 26, 2023, with Orphan Drug and Rare Pediatric Disease designation.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:17 pm

PHUN

Phunware, Inc. (NASDAQ:PHUN) has announced a multi-year partnership with Escapades Memphrémagog, part of PAL+, to enhance guest experiences in Quebec's Eastern Townships through its Hospitality Solution. This solution will provide personalized mobile applications for guests on the Grand Cru cruise boat, and at Espace 4 Saisons and Verso hotels, featuring content-rich experiences, context-aware notifications, and location-based services for navigation and wayfinding.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:15 pm

VYNE

VYNE Therapeutics announced it will present positive safety and efficacy data for its novel BET inhibitor, VYN201, at the 2024 Global Vitiligo Foundation Annual Scientific Symposium on March 7, 2024. The data comes from a Phase 1b trial.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:14 pm

LTBR

Lightbridge CEO Seth Grae provided an update to shareholders, highlighting 2023 achievements and future milestones. Key developments include strengthening the leadership team, agreements with Centrus Energy for a pilot fuel fabrication facility in Ohio, and an engineering study for CANDU reactors with RATEN ICN. Lightbridge also announced a research study with Texas A&M University, NuScale Power, and Structural Integrity Associates, and a significant finding on plutonium disposition. The company is adopting the Technology Readiness Level (TRL) system, currently at TRL 4-5, indicating progress towards commercialization. Upcoming milestones include expanding the fuel development team, ongoing work at Idaho National Laboratory, completing the CANDU reactor study, the FEED study with Centrus, and commencing manufacturing efforts for irradiation testing. COP28 recognized nuclear energy's role in decarbonization, with a commitment to triple nuclear capacity by 2050, highlighting the demand for Lightbridge's nuclear fuel technology.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:13 pm

DAL

The total solar eclipse on April 8, 2024, will be visible across Mexico, the U.S., and parts of Canada, creating a 'Ring of Fire' effect. Delta Air Lines is offering a special flight for passengers to view the eclipse from the sky. Viewers are advised to use special eclipse glasses or pinhole projectors for safe observation.

Portfolio Pulse from Benzinga Neuro

February 27, 2024 | 1:13 pm